… This analysis explored the prognostic importance of heart rate in patients with heart failure
with reduced ejection fraction in randomized controlled trials comparing beta-blockers and …

… highest in patients without beta blocker treatment irrespective of underlying HR. Our data,
therefore, support the use of beta blockers in all CHF patients. While outcomes in patients with …

… This difference appears to be driven by heart failure hospitalizations. The main … heart failure
rather than beta-blocker doses. BB, beta-blocker; GDMT, guideline-directed medical therapy; …

… We excluded patients with heart failure or left ventricular ejection fraction <35% and …
that these patients should be treated with beta-blockers for cardiovascular risk reduction. …

… -blocker therapy in patients with hypertension but no prior history of CHD or heart failure with
… Previous randomized, controlled trials of β-blocker therapy in patients with hypertension did …

… long-term β-blocker therapy for ≥1 year and β-blocker therapy for <1 year after AMI, we
excluded patients who had not been prescribed any β-blockers within 3 months after hospital …

… This analysis suggests that for patients with heart failure in sinus rhythm, the effect of beta-blockers
on mortality in patients with LVEF 40–49% is similar to that observed with LVEF < 40…

… , beta-blocker therapy has been shown to prevent new onset or recurrent AF in HF patients
with impaired left ventricular … impact of beta-blocker treatment in patients with HFrEF and SR. …

… Inasmuch as patients were not randomized to beta-blocker therapy within this observational
… of patients with similar characteristics who were, vs were not, prescribed beta-blockers. A …

… on the use of beta blocker therapy in patients with heart failure and active cocaine use. …
beta blockers in heart failure patients actively using cocaine. The use of beta blockers in patients …